OnabotulinumtoxinA discontinuation in patients with prior nerve stimulation
Sign Up to like & getrecommendations! Published in 2022 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.25121
Abstract: The objective of this study is to describe the characteristics of patients who discontinue onabotulinumtoxinA treatment for overactive bladder (OAB) and to determine the impact of prior sacroneuromodulation or peripheral nerve stimulation on the discontinuation… read more here.
Keywords: patients prior; nerve stimulation; onabotulinumtoxina discontinuation; stimulation ... See more keywords
Risk Factors for Denosumab Discontinuation in Patients with Postmenopausal Osteoporosis.
Sign Up to like & getrecommendations! Published in 2022 at "Modern rheumatology"
DOI: 10.1093/mr/roac070
Abstract: OBJECTIVES Persistence with treatment is key to achieving successful treatment outcomes in patients with osteoporosis. We investigated risk factors for denosumab discontinuation in patients with postmenopausal osteoporosis (PMO). METHODS A total of 333 patients with… read more here.
Keywords: factors denosumab; denosumab discontinuation; risk factors; discontinuation patients ... See more keywords
Patterns of discontinuation in patients with IPF treated with open-label nintedanib: data from INPULSIS-ON
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa4777
Abstract: INPULSIS®-ON Ulrich Costabel,1 Michael Kreuter,2 Jin Woo Song,3 John T Huggins,4 Benoit Wallaert,5 Wibke Stansen,6 Susanne Stowasser,6 Manuel Quaresma,6 Bruno Crestani7 1Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany; 2Center for Interstitial and Rare Lung… read more here.
Keywords: ipf treated; patterns discontinuation; patients ipf; university ... See more keywords
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Toxins"
DOI: 10.3390/toxins14100675
Abstract: Background: The present study aimed to evaluate the reasons and determinants of BoNT-A discontinuation in patients with stroke, multiple sclerosis, spinal cord injury, and traumatic brain injury. Methods: It is a retrospective study of 56… read more here.
Keywords: bont treatment; determinants bont; reasons determinants; discontinuation patients ... See more keywords